Pierre Beaurang

Dr. Beaurang is a former CEO of Nitrase Therapeutics and an expert in oncology and immunology. He has been Chief Business Officer at Nurix Therapeutics and a founding member and Executive Director of Business Development at Five Prime Therapeutics. He holds a PhD in molecular and cell biology.